Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
IDEXX Reference Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | environmental violation | 2009 | AZ-DEQ | $80,000 |
Phibro-Tech Inc. | Phibro Animal Health | pharmaceuticals | environmental violation | 2019 | CA-DTSC | $495,000 |
Neutrogena Corp. | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | CA-DTSC | $416,248 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | environmental violation | 2010 | CT-ENV | $31,266 |
Pfizer Inc. | Pfizer | pharmaceuticals | environmental violation | 2006 | CT-ENV | $40,224 |
SIGMA-ALDRICH MANUFACTURING | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2014 | IL-ENV | $12,500 |
PHARMACIA CORPORATION, et al. | Pfizer | pharmaceuticals | environmental violation | 2009 | IL-ENV | $96,000 |
PHARMACIA/SOLUTIA | Pfizer | pharmaceuticals | environmental violation | 2007 | IL-ENV | $210,000 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2021 | MA-AG | $600,000 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2006 | MA-ENV | $11,600 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | pharmaceuticals | environmental violation | 2003 | MA-ENV | $15,500 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2002 | MA-ENV | $15,000 |
Novo Nordisk Pharmaceutical Industries, Inc. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | NC-ENV | $36,836 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2009 | NJ-ENV | $10,000 |
AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2018 | NY-ENV | $21,250 |
GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
AMRI Rensselaer, Inc. | Curia Inc. | pharmaceuticals | environmental violation | 2014 | NY-ENV | $45,000 |
Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | environmental violation | 2014 | NY-ENV | $7,499 |
EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2008 | OH-ENV | $30,700 |
EMD Chemicals Inc. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2005 | OH-ENV | $32,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2020 | VA-ENV | $20,925 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2019 | VA-ENV | $17,290 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2023 | MA-ENV | $11,615 |
ADVANCED STERILIZATION PRODUCTS INC | Johnson & Johnson | pharmaceuticals | environmental violation | 2023 | NJ-ENV | $13,300 |
PFIZER INC / GROTON SITE | Pfizer | pharmaceuticals | environmental violation | 2005 | EPA | $22,500 |
MILLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2010 | EPA | $526,500 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
LILLY DEL CARIBE INC | Eli Lilly | pharmaceuticals | environmental violation | 2000 | EPA | $39,000 |
PHARMACIA & UPJOHN CARIBE | Pfizer | pharmaceuticals | environmental violation | 2001 | EPA | $27,168 |
Phibro Animal Health Corporation | Phibro Animal Health | pharmaceuticals | environmental violation | 2006 | EPA | $82,467 |
Schering Plough Products, LLC | Merck | pharmaceuticals | environmental violation | 2010 | EPA | $11,500 |
Janssen Pharmaceutical (SB) | Johnson & Johnson | pharmaceuticals | environmental violation | 2010 | EPA | $105,000 |
NOVOZYMES BIOLOGICALS, INC | Novo Holdings A/S | pharmaceuticals | environmental violation | 2009 | EPA | $26,797 |
MERCK SHARP & DOHME CORPORATION | Merck | pharmaceuticals | environmental violation | 2012 | EPA | $69,274 |
NOVOZYMES BIOLOGICALS, INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2016 | EPA | $8,400 |
EM INDUSTRIES, INC. | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
NOVO NORDISK BIOCHEM, N.A., INC. | Novo Holdings A/S | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
UCB CHEMICAL CORPORATION | UCB | pharmaceuticals | environmental violation | 2001 | EPA | $6,824 |
MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB) | Merck | pharmaceuticals | environmental violation | 2007 | EPA | $40,950 |
ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
LAFAYETTE PHARMACEUTICALS, INC. | Mallinckrodt | pharmaceuticals | environmental violation | 2001 | EPA | $17,600 |
ALPHARMA, INC. | Zoetis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
PHIBRO-TECH, INC. | Phibro Animal Health | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
PHARMACIA & UPJOHN COMPANY, LLC. | Pfizer | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
Novartis Animal Health US, Inc. | Eli Lilly | pharmaceuticals | environmental violation | 2006 | EPA | $6,500 |
Alpharma Inc. (Chicago Heights) | Zoetis | pharmaceuticals | environmental violation | 2006 | EPA | $29,737 |
Pharmacia and Upjohn Company LLC | Pfizer | pharmaceuticals | environmental violation | 2017 | EPA | $34,170 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Genentech | Roche | pharmaceuticals | environmental violation | 2023 | EPA | $158,209 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
NOVARTIS PRODUCTS | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $13,200 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
Amneal Pharmaceuticals of NY, LLC | Amneal Pharmaceuticals | pharmaceuticals | employment discrimination | 2015 | OFCCP | $99,000 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | employment discrimination | 2013 | OFCCP | $51,594 |
Roche Diagnostics Corporation | Roche | pharmaceuticals | employment discrimination | 2018 | OFCCP | $261,782 |
Hoffmann-La Roche, Inc. | Roche | pharmaceuticals | employment discrimination | 2012 | private lawsuit-federal | $545,833 |
Merck & Company, Inc. | Merck | pharmaceuticals | employment discrimination | 2019 | OFCCP | $289,755 |
IDEXX Laboratories, Inc. | IDEXX Laboratories | pharmaceuticals | employment discrimination | 2020 | OFCCP | $200,000 |
Boehringer Ingelheim Animal Health USA Inc. | Boehringer Ingelheim | pharmaceuticals | employment discrimination | 2020 | OFCCP | $379,089 |
Perrigo Company | Perrigo | pharmaceuticals | employment discrimination | 2021 | NY-NYCCHR | $20,000 |
GNC | Harbin Pharmaceutical Group | pharmaceuticals | employment discrimination | 2019 | NY-NYCCHR | $35,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2021 | OFCCP | $560,000 |
EMD Chemicals, Inc. | Merck KGaA (EMD) | pharmaceuticals | economic sanction violation | 2007 | OFAC | $8,250 |
Chiron Corporation Ltd | Novartis | pharmaceuticals | economic sanction violation | 2004 | OFAC | $168,500 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | pharmaceuticals | economic sanction violation | 2004 | OFAC | $6,600 |
Fort Dodge Animal Health | Zoetis | pharmaceuticals | economic sanction violation | 2004 | OFAC | $26,956 |
ICN Pharmaceuticals, Inc | Bausch Health | pharmaceuticals | economic sanction violation | 2004 | OFAC | $5,500 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Genzyme Corporation | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2015 | FDA | $32,587,439 |
Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | FDA | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Roussel Uclaf S.A. | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $120,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
Pfizer | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2003 | MULTI-AG | $6,000,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2012 | OR-AG | $3,340,000 |
Purdue Pharma | Purdue Pharma | pharmaceuticals | drug or medical equipment safety violation | 2015 | KY-AG | $24,000,000 |
Ranbaxy Laboratories | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
Wyeth-Ayerst Laboratories Division | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2000 | FDA | $30,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | drug or medical equipment safety violation | 2014 | NV-AG | $9,500,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Controlled Substances Act violation | 2008 | USAO | $511,000 |
Anda | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Purdue Frederick Company, Inc. and Purdue Pharma, L.P. | Purdue Pharma | pharmaceuticals | Controlled Substances Act violation | 2007 | NV-AG | $1,047,787 |
Purdue Pharma, L.P. | Purdue Pharma | pharmaceuticals | Controlled Substances Act violation | 2015 | NY-AG | $75,000 |
Mylan Laboratories, Inc. | Viatris | pharmaceuticals | consumer protection violation | 2000 | FTC | $100,000,000 |
Abbott Laboratories | Abbott Laboratories | pharmaceuticals | consumer protection violation | 2018 | NY-AG | $50,000 |